Sir,
====

Lee et al^[@R1]^ postulate that biofilm surrounding breast implants causes breast implant illness (BII). Formerly called human adjuvant disease,^[@R2]^ this topic has generated renewed interest.^[@R2]--[@R4]^

Fifty BII patients requesting explantation and 50 implant replacement (control) patients underwent "en bloc" removal of their breast implants and capsules.^[@R1]^ This term is usually reserved for describing removal of tissue adjacent to a tumor, such as breast implant--associated anaplastic large-cell lymphoma (BIA-ALCL).^[@R4]^

The authors' 56-point list of BII symptoms included ubiquitous ailments such as headache, rashes, dry skin, hair loss, fatigue, joint pain, and anxiety.^[@R1]^ The authors report that the 50 control patients "had no BII symptoms reported on administration of the same preoperative questionnaire."^[@R1]^ This finding is extraordinary. By comparison, a global survey finds that 19.1% of people suffer from tension headaches, 43.6% experience dermatitis, and 26.1% have an anxiety disorder.^[@R5]^

Remarkably few organisms were cultured: 12 cultures produced *Propionibacterium acnes*; 6 cultures grew *Staphylococcus epidermidis*; 1 culture produced a Gram-negative bacillus; and 1 culture was polymicrobial. By contrast, Walker et al^[@R6]^ identified over 25 different bacteria in their study of BIA-ALCL specimens and controls using cultures, 16S rRNA microbiome sequencing, and immunohistochemistry. The most abundant bacterial genus was *Propionibacterium*.^[@R6]^

The authors conclude that implant removal and capsulectomy is an effective treatment for BII.^[@R1]^ This conclusion is open to question. The capsule is not a microbiological barrier. *P. acnes* and *S. epidermidis* are frequently cultured from normal breast tissue and skin.^[@R6],[@R7]^ The microbiomes of skin, breast, and capsular tissue tend to be similar for a particular patient, rather than to other people with the same condition or disease.^[@R6]^ Thornton et al^[@R7]^ found that coagulase-negative *Staphylococcus* was the most prevalent aerobe (53%) and *P. acnes* was the most common anaerobe (39%) in primary augmentation and reduction patients, and that these bacteria are evenly concentrated throughout the breast parenchyma.^[@R7]^ Consequently, these commensal organisms are unlikely to be eradicated by surgery.^[@R7]^

Other investigators also report symptomatic improvement after explantation in some patients.^[@R3],[@R8]^ Caution is needed when interpreting these subjective findings. According to a large survey, the satisfaction rate after acupuncture is about 90%.^[@R9]^ An admission that surgery was ineffective would create cognitive dissonance.

Differentiating correlation and causation is challenging.^[@R4]^ Over a century ago, physicians were similarly faced with the problem of linking bacteria to disease. In 1890, Koch^[@R10]^ introduced criteria for a causal relationship. Evidence of the bacteria must be present in every case of the disease. This standard has not been met for any microbe as a cause of capsular contracture, BIA-ALCL, or BII.^[@R4],[@R6],[@R7]^

The role of capsulectomy is unclear in this patient group because there is no known physical cause for BII.^[@R3],[@R4]^ Whether the implant or the capsule is responsible or both (or none) is unknown.^[@R4]^ Capsulectomy adds morbidity without a known systemic benefit.^[@R4]^ In the absence of capsular pathology, explantation alone, without capsulectomy, is an acceptable choice.^[@R4]^ Women's request for explantation should be honored; it is their decision.^[@R3],[@R4],[@R8]^ However, they deserve to be informed of the lack of any reliable scientific data supporting efficacy.^[@R3],[@R4]^
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